Published in Anesthesiology on September 01, 2012
Toll like receptor (TLR)-4 as a regulator of peripheral endogenous opioid-mediated analgesia in inflammation. Mol Pain (2014) 0.85
Molecular and cellular mechanisms that initiate pain and itch. Cell Mol Life Sci (2015) 0.84
CD11b+Ly6G- myeloid cells mediate mechanical inflammatory pain hypersensitivity. Proc Natl Acad Sci U S A (2015) 0.82
DNA Methylation Modulates Nociceptive Sensitization after Incision. PLoS One (2015) 0.78
Opioids enhance CXCL1 expression and function after incision in mice. J Pain (2014) 0.78
Sigma-1 receptors control immune-driven peripheral opioid analgesia during inflammation in mice. Proc Natl Acad Sci U S A (2017) 0.75
Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain (1988) 18.17
Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg (2003) 7.95
Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol (2007) 7.80
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J Immunol (1991) 5.02
The neutrophil: function and regulation in innate and humoral immunity. Clin Immunol (2001) 2.31
Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am J Pathol (1998) 2.09
Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J Leukoc Biol (2006) 1.75
Pathophysiology of peripheral neuropathic pain: immune cells and molecules. Anesth Analg (2007) 1.73
Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol (2008) 1.64
Depletion of Ly6G/Gr-1 leukocytes after spinal cord injury in mice alters wound healing and worsens neurological outcome. J Neurosci (2009) 1.35
Characterization of Adelta- and C-fibers innervating the plantar rat hindpaw one day after an incision. J Neurophysiol (2002) 1.32
The role of interleukin-1 in wound biology. Part II: In vivo and human translational studies. Anesth Analg (2010) 1.32
Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain (2007) 1.31
Complement alternative pathway acts as a positive feedback amplification of neutrophil activation. Blood (2010) 1.31
Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav Brain Res (2005) 1.25
The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors. Anesth Analg (1998) 1.24
A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res (2001) 1.24
Hyperalgesia due to nerve injury: role of neutrophils. Neuroscience (2000) 1.23
Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci (1995) 1.23
Postoperative pain management: study of patients' level of pain and satisfaction with health care providers' responsiveness to their reports of pain. Nurs Health Sci (2003) 1.22
Regulated proenkephalin expression in human skin and cultured skin cells. J Invest Dermatol (2010) 1.17
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain (2009) 1.17
Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology (2006) 1.16
The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain (2009) 1.15
Opioid-induced hyperalgesia and incisional pain. Anesth Analg (2001) 1.14
A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain (2003) 1.11
Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology (2003) 1.10
beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol (2001) 1.10
The epidermis: a sensory tissue. Eur J Dermatol (2008) 1.07
Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain (2009) 1.07
Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve. J Neuroimmunol (2007) 1.05
Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. Immunobiology (1996) 1.05
Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest (2009) 1.00
Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain (2004) 0.99
Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats. Neuropeptides (2003) 0.96
Opioid receptors and opioid peptide-producing leukocytes in inflammatory pain--basic and therapeutic aspects. Brain Behav Immun (2009) 0.95
Effects of inflammatory cytokines on the permeability of human lung microvascular endothelial cell monolayers and differential eosinophil transmigration. J Allergy Clin Immunol (2002) 0.95
Activation of complement in normal serum by hydrogen peroxide and hydrogen peroxide-related oxygen radicals produced by activated neutrophils. Clin Exp Immunol (1992) 0.93
Sustained nociceptive mechanical stimulation of latent myofascial trigger point induces central sensitization in healthy subjects. J Pain (2010) 0.91
Increased local concentration of complement C5a contributes to incisional pain in mice. J Neuroinflammation (2011) 0.89
Nociceptive sensitization by complement C5a and C3a in mouse. Pain (2009) 0.89
Increased sensitivity of group III and group IV afferents from incised muscle in vitro. Pain (2010) 0.89
Caspase-1 modulates incisional sensitization and inflammation. Anesthesiology (2010) 0.88
Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol (2005) 0.87
Did experimenter bias conceal the efficacy of spinal opioids in previous studies with the spinal nerve ligation model of neuropathic pain? Anesthesiology (2004) 0.82
Antinociception by neutrophil-derived opioid peptides in noninflamed tissue--role of hypertonicity and the perineurium. Brain Behav Immun (2009) 0.81
Expression of proenkephalin (PENK) mRNA in inflammatory leukocytes during experimental peritonitis in Swiss mice. Pol J Pharmacol (2002) 0.80
Leukocytes as mediators of pain and analgesia. Curr Rheumatol Rep (2007) 0.80
Inflammasome activation in delayed-type hypersensitivity reactions. J Invest Dermatol (2007) 0.78
Vascular permeability changes induced by complement-derived peptides. Agents Actions (1983) 0.77
Propiomelanocortin (POMC) gene expression by normal skin and keloid fibroblasts in culture: modulation by cytokines. Exp Dermatol (1997) 0.77
Functional evidence of pain control by the immune system. Adv Exp Med Biol (2003) 0.77
Effects of opiate agonists and antagonists on cerebral metabolic activity in the conscious rat. NIDA Res Monogr (1990) 0.76
Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology (2006) 3.81
Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology (2012) 2.85
Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain (2012) 2.44
A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology (2006) 1.97
Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology (2012) 1.64
Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res (2007) 1.58
Patient characteristics associated with opioid versus nonsteroidal anti-inflammatory drug management of chronic low back pain. J Pain (2003) 1.58
No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans. Pain (2009) 1.58
Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome. Anesthesiology (2014) 1.56
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med (2005) 1.34
The role of interleukin-1 in wound biology. Part II: In vivo and human translational studies. Anesth Analg (2010) 1.32
Sex differences in reported pain across 11,000 patients captured in electronic medical records. J Pain (2012) 1.32
Morphine reduces local cytokine expression and neutrophil infiltration after incision. Mol Pain (2007) 1.31
Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res (2004) 1.22
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain (2009) 1.17
The role of interleukin-1 in wound biology. Part I: Murine in silico and in vitro experimental analysis. Anesth Analg (2010) 1.16
Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence. Pain (2006) 1.16
Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology (2006) 1.16
The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain (2009) 1.15
Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision. Mol Pain (2008) 1.13
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain (2008) 1.13
Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain (2008) 1.12
A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain (2003) 1.11
From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics. Pharmacogenet Genomics (2009) 1.11
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11
Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain (2010) 1.09
Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain (2009) 1.07
Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes. Pharmacogenet Genomics (2008) 1.05
Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology (2002) 1.04
Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice. J Pain (2013) 0.98
Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytes. Anesth Analg (2011) 0.96
Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome. Mol Pain (2012) 0.96
Alterations in spinal cord gene expression after hindpaw formalin injection. J Neurosci Res (2004) 0.96
miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression. Anesthesiology (2012) 0.96
The beta2 adrenergic receptor regulates morphine tolerance and physical dependence. Behav Brain Res (2007) 0.95
A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone (2003) 0.95
Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone (2009) 0.95
5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice. Anesthesiology (2011) 0.94
Activation of alpha2 adrenergic receptors suppresses fear conditioning: expression of c-Fos and phosphorylated CREB in mouse amygdala. Neuropsychopharmacology (2004) 0.94
Bone microstructure and its associated genetic variability in 12 inbred mouse strains: microCT study and in silico genome scan. Bone (2007) 0.90
Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol (2009) 0.90
Opioid pharmacogenomics using a twin study paradigm: methods and procedures for determining familial aggregation and heritability. Twin Res Hum Genet (2010) 0.89
Nociceptive sensitization by complement C5a and C3a in mouse. Pain (2009) 0.89
Spinal CK2 regulates nociceptive signaling in models of inflammatory pain. Pain (2005) 0.89
Changes resembling complex regional pain syndrome following surgery and immobilization. J Pain (2013) 0.89
Caspase-1 modulates incisional sensitization and inflammation. Anesthesiology (2010) 0.88
Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites. Brain Res (2006) 0.87
Pharmacological profiles of opioid ligands at kappa opioid receptors. BMC Pharmacol (2006) 0.87
The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model. Pain (2011) 0.87
Modulation of the NO/CO-cGMP signaling cascade during chronic morphine exposure in mice. Neurosci Lett (2004) 0.87
Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors. BMC Neurosci (2002) 0.87
Formalin-induced spinal cord calcium/calmodulin-dependent protein kinase II alpha expression is modulated by heme oxygenase in mice. Neurosci Lett (2004) 0.87
Expression genetics identifies spinal mechanisms supporting formalin late phase behaviors. Mol Pain (2010) 0.86
Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome. Pain (2013) 0.86
Epigenetic regulation of spinal CXCR2 signaling in incisional hypersensitivity in mice. Anesthesiology (2013) 0.85
Acute and chronic phases of complex regional pain syndrome in mice are accompanied by distinct transcriptional changes in the spinal cord. Mol Pain (2013) 0.83
Hyperalgesia during opioid abstinence: mediation by glutamate and substance p. Anesth Analg (2002) 0.83
Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice. J Pain (2012) 0.82
Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth Analg (2003) 0.82
Ketamine for managing perioperative pain in opioid-dependent patients with chronic pain: a unique indication? Anesthesiology (2010) 0.81
Curcumin treatment attenuates pain and enhances functional recovery after incision. Anesth Analg (2014) 0.80
Transcutaneous blood gas CO2 monitoring of induced ventilatory depression in mice. Anesth Analg (2006) 0.80
Augmentation of the noradrenergic system in alpha-2 adrenergic receptor deficient mice: anatomical changes associated with enhanced fear memory. Brain Res (2003) 0.80
Spinal cord heme oxygenase participates in glutamate-induced pain-related behaviors. Eur J Pharmacol (2002) 0.79
Integrative approach to pain genetics identifies pain sensitivity loci across diseases. PLoS Comput Biol (2012) 0.79
Understanding our drugs and our diseases. Proc Am Thorac Soc (2006) 0.79
Heme oxygenase type 2 participates in the development of chronic inflammatory and neuropathic pain. J Pain (2003) 0.79
Opioid medication management: clinician beware! Anesthesiology (2010) 0.78
Understanding methadone metabolism: a foundation for safer use. Anesthesiology (2008) 0.78
Epigenetic regulation of spinal cord gene expression controls opioid-induced hyperalgesia. Mol Pain (2014) 0.78
Effects of methyl donor diets on incisional pain in mice. PLoS One (2013) 0.77
Sleep quality and the role of sleep medications for veterans with chronic pain. Pain Med (2006) 0.77
Dietary methyl content regulates opioid responses in mice. J Pain Res (2013) 0.77
Formalin injection causes a coordinated spinal cord CO/NO-cGMP signaling system response. Mol Pain (2005) 0.76
The role of the extracellular matrix in chronic pain following injury. Pain (2015) 0.76